| Symbol |
Name |
Standardized Value |
|
PTH
|
parathyroid hormone
|
4.0
|
|
CASR
|
calcium-sensing receptor
|
3.852
|
|
FGF23
|
fibroblast growth factor 23
|
3.813
|
|
MEN1
|
multiple endocrine neoplasia I
|
3.656
|
|
CDC73
|
cell division cycle 73
|
3.572
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
3.318
|
|
KL
|
klotho
|
3.237
|
|
PTHLH
|
parathyroid hormone-like hormone
|
3.183
|
|
ALB
|
albumin
|
3.081
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
3.017
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
2.996
|
|
RET
|
ret proto-oncogene
|
2.992
|
|
SOST
|
sclerostin
|
2.964
|
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1
|
2.9
|
|
GCM2
|
glial cells missing homolog 2 (Drosophila)
|
2.896
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
2.881
|
|
GC
|
group-specific component (vitamin D binding protein)
|
2.863
|
|
EPO
|
erythropoietin
|
2.81
|
|
AP2S1
|
adaptor-related protein complex 2, sigma 1 subunit
|
2.799
|
|
PHEX
|
phosphate regulating endopeptidase homolog, X-linked
|
2.79
|
|
PTH1R
|
parathyroid hormone 1 receptor
|
2.782
|
|
REN
|
renin
|
2.778
|
|
ACP5
|
acid phosphatase 5, tartrate resistant
|
2.744
|
|
SLC34A3
|
solute carrier family 34 (type II sodium/phosphate cotransporter), member 3
|
2.743
|
|
GAST
|
gastrin
|
2.72
|
|
SLC34A1
|
solute carrier family 34 (type II sodium/phosphate cotransporter), member 1
|
2.592
|
|
EMP1
|
epithelial membrane protein 1
|
2.587
|
|
INS
|
insulin
|
2.579
|
|
MGP
|
matrix Gla protein
|
2.569
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
2.54
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
2.514
|
|
CYP2R1
|
cytochrome P450, family 2, subfamily R, polypeptide 1
|
2.51
|
|
CRP
|
C-reactive protein, pentraxin-related
|
2.507
|
|
TRPV5
|
transient receptor potential cation channel, subfamily V, member 5
|
2.504
|
|
GNA11
|
guanine nucleotide binding protein (G protein), alpha 11 (Gq class)
|
2.471
|
|
TRPV6
|
transient receptor potential cation channel, subfamily V, member 6
|
2.457
|
|
RUNX2
|
runt-related transcription factor 2
|
2.45
|
|
PRL
|
prolactin
|
2.445
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
2.444
|
|
SPP1
|
secreted phosphoprotein 1
|
2.386
|
|
DMP1
|
dentin matrix acidic phosphoprotein 1
|
2.385
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
2.383
|
|
ACE
|
angiotensin I converting enzyme
|
2.367
|
|
IL6
|
interleukin 6
|
2.357
|
|
ATP4A
|
ATPase, H+/K+ exchanging, alpha polypeptide
|
2.351
|
|
ATP12A
|
ATPase, H+/K+ transporting, nongastric, alpha polypeptide
|
2.351
|
|
CYP27A1
|
cytochrome P450, family 27, subfamily A, polypeptide 1
|
2.348
|
|
POMC
|
proopiomelanocortin
|
2.341
|
|
GALNT3
|
polypeptide N-acetylgalactosaminyltransferase 3
|
2.325
|
|
CHGA
|
chromogranin A
|
2.317
|
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
2.234
|
|
MEPE
|
matrix extracellular phosphoglycoprotein
|
2.23
|
|
SST
|
somatostatin
|
2.217
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
2.216
|
|
SLC20A2
|
solute carrier family 20 (phosphate transporter), member 2
|
2.209
|
|
SP7
|
Sp7 transcription factor
|
2.196
|
|
TNF
|
tumor necrosis factor
|
2.185
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
2.166
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
2.165
|
|
FGF7
|
fibroblast growth factor 7
|
2.15
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
2.15
|
|
S100G
|
S100 calcium binding protein G
|
2.146
|
|
FGF3
|
fibroblast growth factor 3
|
2.144
|
|
FGF16
|
fibroblast growth factor 16
|
2.133
|
|
GNAS
|
GNAS complex locus
|
2.132
|
|
FGF22
|
fibroblast growth factor 22
|
2.131
|
|
FGF17
|
fibroblast growth factor 17
|
2.13
|
|
CTSK
|
cathepsin K
|
2.13
|
|
FGF6
|
fibroblast growth factor 6
|
2.129
|
|
FGF20
|
fibroblast growth factor 20
|
2.128
|
|
FGF18
|
fibroblast growth factor 18
|
2.128
|
|
FGF9
|
fibroblast growth factor 9
|
2.126
|
|
FGF5
|
fibroblast growth factor 5
|
2.125
|
|
LEP
|
leptin
|
2.118
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
2.117
|
|
GCG
|
glucagon
|
2.116
|
|
CTR9
|
CTR9, Paf1/RNA polymerase II complex component
|
2.115
|
|
FGF4
|
fibroblast growth factor 4
|
2.112
|
|
FGF10
|
fibroblast growth factor 10
|
2.111
|
|
LRP5
|
low density lipoprotein receptor-related protein 5
|
2.11
|
|
ESR1
|
estrogen receptor 1
|
2.096
|
|
CCND1
|
cyclin D1
|
2.086
|
|
PPY
|
pancreatic polypeptide
|
2.086
|
|
SCT
|
secretin
|
2.076
|
|
B2M
|
beta-2-microglobulin
|
2.071
|
|
IL1B
|
interleukin 1, beta
|
2.057
|
|
TG
|
thyroglobulin
|
2.055
|
|
LEO1
|
Leo1, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae)
|
2.054
|
|
CLDN16
|
claudin 16
|
2.051
|
|
BMP2
|
bone morphogenetic protein 2
|
2.044
|
|
COL1A2
|
collagen, type I, alpha 2
|
2.041
|
|
APOM
|
apolipoprotein M
|
2.04
|
|
LRP2
|
low density lipoprotein receptor-related protein 2
|
2.017
|
|
TGFB1
|
transforming growth factor, beta 1
|
2.012
|
|
NR0B2
|
nuclear receptor subfamily 0, group B, member 2
|
2.004
|
|
GHRH
|
growth hormone releasing hormone
|
1.991
|
|
NF1
|
neurofibromin 1
|
1.98
|
|
PTH2R
|
parathyroid hormone 2 receptor
|
1.978
|
|
CST3
|
cystatin C
|
1.962
|
|
SLC34A2
|
solute carrier family 34 (type II sodium/phosphate cotransporter), member 2
|
1.957
|
|
TMEM127
|
transmembrane protein 127
|
1.954
|
|
SDHD
|
succinate dehydrogenase complex, subunit D, integral membrane protein
|
1.953
|
|
ALPG
|
alkaline phosphatase, germ cell
|
1.951
|
|
IL1A
|
interleukin 1, alpha
|
1.947
|
|
CDKN2C
|
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
|
1.919
|
|
ALPI
|
alkaline phosphatase, intestinal
|
1.917
|
|
IBSP
|
integrin-binding sialoprotein
|
1.912
|
|
HAMP
|
hepcidin antimicrobial peptide
|
1.911
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
1.904
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
1.902
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
1.901
|
|
CLDN14
|
claudin 14
|
1.898
|
|
ALPP
|
alkaline phosphatase, placental
|
1.894
|
|
KCNJ1
|
potassium channel, inwardly rectifying subfamily J, member 1
|
1.879
|
|
DNAH8
|
dynein, axonemal, heavy chain 8
|
1.873
|
|
VIP
|
vasoactive intestinal peptide
|
1.873
|
|
SYP
|
synaptophysin
|
1.863
|
|
WNT10B
|
wingless-type MMTV integration site family, member 10B
|
1.861
|
|
CLDN19
|
claudin 19
|
1.859
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
1.846
|
|
ANKH
|
ANKH inorganic pyrophosphate transport regulator
|
1.84
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
1.819
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
1.807
|
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta
|
1.788
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
1.787
|
|
PRKACG
|
protein kinase, cAMP-dependent, catalytic, gamma
|
1.784
|
|
RTF1
|
Rtf1, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae)
|
1.783
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
1.778
|
|
SH3BP2
|
SH3-domain binding protein 2
|
1.774
|
|
MSX2
|
msh homeobox 2
|
1.773
|
|
AVP
|
arginine vasopressin
|
1.765
|
|
SLC20A1
|
solute carrier family 20 (phosphate transporter), member 1
|
1.76
|
|
PTH2
|
parathyroid hormone 2
|
1.758
|
|
CALB1
|
calbindin 1, 28kDa
|
1.755
|
|
TRPM6
|
transient receptor potential cation channel, subfamily M, member 6
|
1.744
|
|
GPRC6A
|
G protein-coupled receptor, class C, group 6, member A
|
1.743
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
1.739
|
|
NPPB
|
natriuretic peptide B
|
1.735
|
|
FAM20C
|
family with sequence similarity 20, member C
|
1.731
|
|
SLC5A2
|
solute carrier family 5 (sodium/glucose cotransporter), member 2
|
1.723
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
1.719
|
|
SLC12A1
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 1
|
1.71
|
|
SFRP4
|
secreted frizzled-related protein 4
|
1.71
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
1.699
|
|
SHBG
|
sex hormone-binding globulin
|
1.697
|
|
SDHAF2
|
succinate dehydrogenase complex assembly factor 2
|
1.696
|
|
ADH1A
|
alcohol dehydrogenase 1A (class I), alpha polypeptide
|
1.694
|
|
COL1A1
|
collagen, type I, alpha 1
|
1.689
|
|
CUBN
|
cubilin (intrinsic factor-cobalamin receptor)
|
1.676
|
|
FNDC5
|
fibronectin type III domain containing 5
|
1.669
|
|
JUND
|
jun D proto-oncogene
|
1.668
|
|
SDHA
|
succinate dehydrogenase complex, subunit A, flavoprotein (Fp)
|
1.662
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
1.66
|
|
SLC12A3
|
solute carrier family 12 (sodium/chloride transporter), member 3
|
1.657
|
|
BMP7
|
bone morphogenetic protein 7
|
1.654
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
1.653
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
1.651
|
|
PRUNE2
|
prune homolog 2 (Drosophila)
|
1.649
|
|
NPPA
|
natriuretic peptide A
|
1.646
|
|
IFNG
|
interferon, gamma
|
1.642
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
1.642
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
1.641
|
|
CD4
|
CD4 molecule
|
1.639
|
|
CSH1
|
chorionic somatomammotropin hormone 1 (placental lactogen)
|
1.636
|
|
CLCN5
|
chloride channel, voltage-sensitive 5
|
1.631
|
|
TP53
|
tumor protein p53
|
1.631
|
|
CSH2
|
chorionic somatomammotropin hormone 2
|
1.624
|
|
HRH2
|
histamine receptor H2
|
1.624
|
|
IL17A
|
interleukin 17A
|
1.614
|
|
TGFA
|
transforming growth factor, alpha
|
1.605
|
|
FDPS
|
farnesyl diphosphate synthase
|
1.605
|
|
IL10
|
interleukin 10
|
1.604
|
|
ADCK1
|
aarF domain containing kinase 1
|
1.599
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
1.594
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
1.586
|
|
MSTN
|
myostatin
|
1.583
|
|
STX16
|
syntaxin 16
|
1.581
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
1.578
|
|
SDHC
|
succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa
|
1.576
|
|
UMOD
|
uromodulin
|
1.575
|
|
GH1
|
growth hormone 1
|
1.571
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
1.568
|
|
PXDN
|
peroxidasin
|
1.566
|
|
PXDNL
|
peroxidasin-like
|
1.564
|
|
TCHP
|
trichoplein, keratin filament binding
|
1.554
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
1.554
|
|
EDN1
|
endothelin 1
|
1.54
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
1.536
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
1.535
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
1.529
|
|
PHOSPHO1
|
phosphatase, orphan 1
|
1.526
|
|
TTR
|
transthyretin
|
1.525
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
1.524
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
1.523
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
1.515
|
|
TGM2
|
transglutaminase 2
|
1.498
|
|
GPR101
|
G protein-coupled receptor 101
|
1.497
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
1.495
|
|
UCMA
|
upper zone of growth plate and cartilage matrix associated
|
1.495
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
1.489
|
|
CKM
|
creatine kinase, muscle
|
1.488
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
1.486
|
|
ELN
|
elastin
|
1.485
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
1.484
|
|
CTRC
|
chymotrypsin C (caldecrin)
|
1.483
|
|
CKB
|
creatine kinase, brain
|
1.483
|
|
GDNF
|
glial cell derived neurotrophic factor
|
1.483
|
|
CKMT2
|
creatine kinase, mitochondrial 2 (sarcomeric)
|
1.48
|
|
CKMT1B
|
creatine kinase, mitochondrial 1B
|
1.479
|
|
ZFX
|
zinc finger protein, X-linked
|
1.478
|
|
SSTR2
|
somatostatin receptor 2
|
1.476
|
|
PCNA
|
proliferating cell nuclear antigen
|
1.475
|
|
GH2
|
growth hormone 2
|
1.473
|
|
TPO
|
thyroid peroxidase
|
1.473
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
1.473
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
1.468
|
|
SDF4
|
stromal cell derived factor 4
|
1.467
|
|
FXYD2
|
FXYD domain containing ion transport regulator 2
|
1.465
|
|
ATP2B1
|
ATPase, Ca++ transporting, plasma membrane 1
|
1.464
|
|
F2
|
coagulation factor II (thrombin)
|
1.46
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
1.457
|
|
HNF1B
|
HNF1 homeobox B
|
1.456
|
|
CLCN7
|
chloride channel, voltage-sensitive 7
|
1.452
|
|
SLC9A3
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3
|
1.452
|
|
FN1
|
fibronectin 1
|
1.451
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
1.451
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
1.45
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
1.444
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
1.441
|
|
GPT2
|
glutamic pyruvate transaminase (alanine aminotransferase) 2
|
1.44
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
1.439
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
1.439
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
1.436
|
|
CLCNKB
|
chloride channel, voltage-sensitive Kb
|
1.436
|
|
PYY
|
peptide YY
|
1.435
|
|
LDLR
|
low density lipoprotein receptor
|
1.432
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
1.432
|
|
ACTB
|
actin, beta
|
1.432
|
|
CALCR
|
calcitonin receptor
|
1.428
|
|
LCN2
|
lipocalin 2
|
1.427
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
1.423
|
|
IGF2
|
insulin-like growth factor 2
|
1.423
|
|
GHR
|
growth hormone receptor
|
1.42
|
|
CD8A
|
CD8a molecule
|
1.416
|
|
CDKN3
|
cyclin-dependent kinase inhibitor 3
|
1.414
|
|
ADH4
|
alcohol dehydrogenase 4 (class II), pi polypeptide
|
1.409
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
1.409
|
|
IL11
|
interleukin 11
|
1.408
|
|
IL2
|
interleukin 2
|
1.407
|
|
NCAM1
|
neural cell adhesion molecule 1
|
1.402
|
|
BMP4
|
bone morphogenetic protein 4
|
1.399
|
|
DHCR7
|
7-dehydrocholesterol reductase
|
1.398
|
|
NOMO3
|
NODAL modulator 3
|
1.395
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
1.395
|
|
PPIG
|
peptidylprolyl isomerase G (cyclophilin G)
|
1.393
|
|
NOMO2
|
NODAL modulator 2
|
1.393
|
|
WNK4
|
WNK lysine deficient protein kinase 4
|
1.39
|
|
MMP9
|
matrix metallopeptidase 9
|
1.386
|
|
NOMO1
|
NODAL modulator 1
|
1.383
|
|
APOE
|
apolipoprotein E
|
1.382
|
|
IL4
|
interleukin 4
|
1.381
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
1.379
|
|
GATA3
|
GATA binding protein 3
|
1.378
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
1.377
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
1.376
|
|
JUN
|
jun proto-oncogene
|
1.374
|
|
CD34
|
CD34 molecule
|
1.373
|
|
KHDRBS3
|
KH domain containing, RNA binding, signal transduction associated 3
|
1.372
|
|
BSND
|
barttin CLCNK-type chloride channel accessory beta subunit
|
1.371
|
|
CALM3
|
calmodulin 3 (phosphorylase kinase, delta)
|
1.365
|
|
NKX2-1
|
NK2 homeobox 1
|
1.364
|
|
EGLN3
|
egl-9 family hypoxia-inducible factor 3
|
1.362
|
|
GGCX
|
gamma-glutamyl carboxylase
|
1.36
|
|
INSR
|
insulin receptor
|
1.36
|
|
RNF20
|
ring finger protein 20, E3 ubiquitin protein ligase
|
1.359
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
1.359
|
|
AGXT
|
alanine-glyoxylate aminotransferase
|
1.358
|
|
AGTR1
|
angiotensin II receptor, type 1
|
1.355
|
|
EGLN2
|
egl-9 family hypoxia-inducible factor 2
|
1.355
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
1.353
|
|
FGF13
|
fibroblast growth factor 13
|
1.349
|
|
MAX
|
MYC associated factor X
|
1.349
|
|
TRH
|
thyrotropin-releasing hormone
|
1.343
|
|
CREB1
|
cAMP responsive element binding protein 1
|
1.343
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
1.338
|
|
LPL
|
lipoprotein lipase
|
1.338
|
|
PAX8
|
paired box 8
|
1.337
|
|
CALML6
|
calmodulin-like 6
|
1.336
|
|
CALML4
|
calmodulin-like 4
|
1.336
|
|
CALML3
|
calmodulin-like 3
|
1.334
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
1.334
|
|
ABCC6
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 6
|
1.334
|
|
CALML5
|
calmodulin-like 5
|
1.333
|
|
TAF8
|
TAF8 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 43kDa
|
1.333
|
|
EGFR
|
epidermal growth factor receptor
|
1.332
|
|
RGS14
|
regulator of G-protein signaling 14
|
1.331
|
|
XDH
|
xanthine dehydrogenase
|
1.327
|
|
PRSS1
|
protease, serine, 1 (trypsin 1)
|
1.327
|
|
APOB
|
apolipoprotein B
|
1.326
|
|
GLP1R
|
glucagon-like peptide 1 receptor
|
1.324
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
1.323
|
|
ARRB2
|
arrestin, beta 2
|
1.319
|
|
CRH
|
corticotropin releasing hormone
|
1.318
|
|
CD68
|
CD68 molecule
|
1.316
|
|
SLC13A2
|
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2
|
1.315
|
|
COL4A3
|
collagen, type IV, alpha 3 (Goodpasture antigen)
|
1.309
|
|
USP6
|
ubiquitin specific peptidase 6
|
1.303
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
1.298
|
|
ARMC5
|
armadillo repeat containing 5
|
1.298
|
|
SMAD3
|
SMAD family member 3
|
1.298
|
|
H3-3B
|
H3.3 histone B
|
1.298
|
|
TSHR
|
thyroid stimulating hormone receptor
|
1.298
|
|
OCRL
|
oculocerebrorenal syndrome of Lowe
|
1.297
|
|
FURIN
|
furin (paired basic amino acid cleaving enzyme)
|
1.295
|
|
FRZB
|
frizzled-related protein
|
1.292
|
|
ESPN
|
espin
|
1.29
|
|
PSPN
|
persephin
|
1.29
|
|
PNMT
|
phenylethanolamine N-methyltransferase
|
1.288
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
1.285
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
1.285
|
|
THRAP3
|
thyroid hormone receptor associated protein 3
|
1.277
|
|
ARRB1
|
arrestin, beta 1
|
1.276
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
1.275
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
1.274
|
|
EPOR
|
erythropoietin receptor
|
1.274
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
1.272
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
1.272
|
|
PLPPR4
|
phospholipid phosphatase related 4
|
1.271
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
1.271
|
|
MYH14
|
myosin, heavy chain 14, non-muscle
|
1.268
|
|
CD40LG
|
CD40 ligand
|
1.267
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
1.266
|
|
XPR1
|
xenotropic and polytropic retrovirus receptor 1
|
1.264
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
1.262
|
|
DPP4
|
dipeptidyl-peptidase 4
|
1.26
|
|
EPAS1
|
endothelial PAS domain protein 1
|
1.26
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
1.26
|
|
KLK3
|
kallikrein-related peptidase 3
|
1.258
|
|
IL18
|
interleukin 18
|
1.258
|
|
EGF
|
epidermal growth factor
|
1.255
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
1.253
|
|
DCSTAMP
|
dendrocyte expressed seven transmembrane protein
|
1.25
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
1.248
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
1.248
|
|
HMGCR
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
1.245
|
|
KCNJ5
|
potassium channel, inwardly rectifying subfamily J, member 5
|
1.243
|
|
GNPTAB
|
N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits
|
1.241
|
|
CA2
|
carbonic anhydrase II
|
1.241
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
1.239
|
|
RTP2
|
receptor (chemosensory) transporter protein 2
|
1.238
|
|
CHSY3
|
chondroitin sulfate synthase 3
|
1.237
|
|
GIP
|
gastric inhibitory polypeptide
|
1.232
|
|
TAC1
|
tachykinin, precursor 1
|
1.231
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
1.231
|
|
RETN
|
resistin
|
1.23
|
|
HNRNPD
|
heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa)
|
1.228
|
|
TCIRG1
|
T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3
|
1.226
|
|
GPX7
|
glutathione peroxidase 7
|
1.226
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
1.225
|
|
GPX6
|
glutathione peroxidase 6
|
1.225
|
|
GPX5
|
glutathione peroxidase 5
|
1.224
|
|
AIRE
|
autoimmune regulator
|
1.224
|
|
SLC25A18
|
solute carrier family 25 (glutamate carrier), member 18
|
1.221
|
|
BAAT
|
bile acid CoA:amino acid N-acyltransferase
|
1.219
|
|
SAMD9
|
sterile alpha motif domain containing 9
|
1.218
|
|
SLC26A6
|
solute carrier family 26 (anion exchanger), member 6
|
1.218
|
|
GPX8
|
glutathione peroxidase 8 (putative)
|
1.218
|
|
FBXO32
|
F-box protein 32
|
1.217
|
|
ZNF410
|
zinc finger protein 410
|
1.216
|
|
ATP6V1B1
|
ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1
|
1.214
|
|
GPX3
|
glutathione peroxidase 3
|
1.213
|
|
GPX2
|
glutathione peroxidase 2
|
1.211
|
|
RETNLB
|
resistin like beta
|
1.211
|
|
IFNA16
|
interferon, alpha 16
|
1.208
|
|
IFNA7
|
interferon, alpha 7
|
1.208
|
|
IFNA8
|
interferon, alpha 8
|
1.207
|
|
IFNA10
|
interferon, alpha 10
|
1.207
|
|
IFNA14
|
interferon, alpha 14
|
1.207
|
|
HIC1
|
hypermethylated in cancer 1
|
1.207
|
|
IFNA21
|
interferon, alpha 21
|
1.207
|
|
WNT16
|
wingless-type MMTV integration site family, member 16
|
1.206
|
|
IFNA5
|
interferon, alpha 5
|
1.206
|
|
ANKS6
|
ankyrin repeat and sterile alpha motif domain containing 6
|
1.202
|
|
IFNA4
|
interferon, alpha 4
|
1.202
|
|
IFNA2
|
interferon, alpha 2
|
1.201
|
|
CCK
|
cholecystokinin
|
1.201
|
|
IFNA6
|
interferon, alpha 6
|
1.2
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
1.2
|
|
APOA1
|
apolipoprotein A-I
|
1.198
|
|
IFNA13
|
interferon, alpha 13
|
1.198
|
|
PIK3C3
|
phosphatidylinositol 3-kinase, catalytic subunit type 3
|
1.197
|
|
RNF40
|
ring finger protein 40, E3 ubiquitin protein ligase
|
1.195
|
|
SFRP1
|
secreted frizzled-related protein 1
|
1.195
|
|
SSTR5
|
somatostatin receptor 5
|
1.193
|
|
MAFB
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B
|
1.191
|
|
TRPM7
|
transient receptor potential cation channel, subfamily M, member 7
|
1.19
|
|
PLPPR3
|
phospholipid phosphatase related 3
|
1.187
|
|
IFNA17
|
interferon, alpha 17
|
1.185
|
|
ARTN
|
artemin
|
1.182
|
|
EGR1
|
early growth response 1
|
1.182
|
|
RHOA
|
ras homolog family member A
|
1.18
|
|
MMP13
|
matrix metallopeptidase 13
|
1.175
|
|
WT1
|
Wilms tumor 1
|
1.17
|
|
ACE2
|
angiotensin I converting enzyme 2
|
1.169
|
|
SMAD2
|
SMAD family member 2
|
1.168
|
|
AVPR2
|
arginine vasopressin receptor 2
|
1.167
|
|
DICER1
|
dicer 1, ribonuclease type III
|
1.166
|
|
LEPR
|
leptin receptor
|
1.166
|
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
1.162
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
1.162
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
1.16
|
|
NPY
|
neuropeptide Y
|
1.16
|
|
PRDM2
|
PR domain containing 2, with ZNF domain
|
1.157
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
1.156
|
|
PTEN
|
phosphatase and tensin homolog
|
1.155
|
|
KIF1B
|
kinesin family member 1B
|
1.155
|
|
BMP6
|
bone morphogenetic protein 6
|
1.154
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
1.152
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
1.152
|
|
UCP1
|
uncoupling protein 1 (mitochondrial, proton carrier)
|
1.15
|
|
KDR
|
kinase insert domain receptor
|
1.148
|
|
SLC2A9
|
solute carrier family 2 (facilitated glucose transporter), member 9
|
1.148
|
|
KCNA3
|
potassium channel, voltage gated shaker related subfamily A, member 3
|
1.146
|
|
TBX1
|
T-box 1
|
1.146
|
|
CSDE1
|
cold shock domain containing E1, RNA-binding
|
1.146
|
|
HAVCR1
|
hepatitis A virus cellular receptor 1
|
1.145
|
|
AMBP
|
alpha-1-microglobulin/bikunin precursor
|
1.143
|
|
CLDN2
|
claudin 2
|
1.141
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
1.141
|
|
SIRT1
|
sirtuin 1
|
1.14
|
|
GRM1
|
glutamate receptor, metabotropic 1
|
1.14
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
1.14
|
|
CDH17
|
cadherin 17, LI cadherin (liver-intestine)
|
1.137
|
|
IFNA1
|
interferon, alpha 1
|
1.136
|
|
CCN2
|
cellular communication network factor 2
|
1.135
|
|
FGF21
|
fibroblast growth factor 21
|
1.134
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
1.134
|
|
NRTN
|
neurturin
|
1.134
|
|
FGF19
|
fibroblast growth factor 19
|
1.133
|
|
BSPRY
|
B-box and SPRY domain containing
|
1.132
|
|
PTRH2
|
peptidyl-tRNA hydrolase 2
|
1.131
|
|
LPA
|
lipoprotein, Lp(a)
|
1.126
|
|
BRCA2
|
breast cancer 2, early onset
|
1.125
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
1.124
|
|
TAGLN
|
transgelin
|
1.124
|
|
FOXN3
|
forkhead box N3
|
1.123
|
|
MME
|
membrane metallo-endopeptidase
|
1.122
|
|
TCF4
|
transcription factor 4
|
1.122
|
|
FH
|
fumarate hydratase
|
1.12
|
|
ICAM1
|
intercellular adhesion molecule 1
|
1.117
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
1.112
|
|
POSTN
|
periostin, osteoblast specific factor
|
1.111
|
|
PAX5
|
paired box 5
|
1.111
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
1.111
|
|
CHKA
|
choline kinase alpha
|
1.11
|
|
GRHPR
|
glyoxylate reductase/hydroxypyruvate reductase
|
1.104
|
|
TH
|
tyrosine hydroxylase
|
1.103
|
|
NPHS1
|
nephrosis 1, congenital, Finnish type (nephrin)
|
1.102
|
|
TPM3
|
tropomyosin 3
|
1.097
|
|
CP
|
ceruloplasmin (ferroxidase)
|
1.094
|
|
IAPP
|
islet amyloid polypeptide
|
1.093
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
1.093
|
|
LOX
|
lysyl oxidase
|
1.091
|
|
GNA12
|
guanine nucleotide binding protein (G protein) alpha 12
|
1.089
|
|
VWF
|
von Willebrand factor
|
1.088
|
|
TLR4
|
toll-like receptor 4
|
1.088
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
1.087
|
|
KLB
|
klotho beta
|
1.087
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
1.085
|
|
CELA1
|
chymotrypsin-like elastase family, member 1
|
1.085
|
|
H3-3A
|
H3.3 histone A
|
1.083
|
|
H3-4
|
H3.4 histone, cluster member
|
1.082
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
1.082
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
1.082
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
1.08
|
|
NTS
|
neurotensin
|
1.078
|
|
H3C13
|
H3 clustered histone 13
|
1.076
|
|
H3-5
|
H3.5 histone
|
1.076
|
|
UBXN11
|
UBX domain protein 11
|
1.073
|
|
SLC22A8
|
solute carrier family 22 (organic anion transporter), member 8
|
1.073
|
|
TBCE
|
tubulin folding cofactor E
|
1.072
|
|
CLCN2
|
chloride channel, voltage-sensitive 2
|
1.072
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
1.072
|
|
ATP6V0A4
|
ATPase, H+ transporting, lysosomal V0 subunit a4
|
1.071
|
|
AR
|
androgen receptor
|
1.07
|
|
SPCS2
|
signal peptidase complex subunit 2 homolog (S. cerevisiae)
|
1.07
|
|
MPO
|
myeloperoxidase
|
1.067
|
|
DNTTIP2
|
deoxynucleotidyltransferase, terminal, interacting protein 2
|
1.066
|
|
SLC8A1
|
solute carrier family 8 (sodium/calcium exchanger), member 1
|
1.066
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
1.065
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
1.064
|
|
H3C12
|
H3 clustered histone 12
|
1.064
|
|
ATP2B3
|
ATPase, Ca++ transporting, plasma membrane 3
|
1.063
|
|
MXD3
|
MAX dimerization protein 3
|
1.061
|
|
SLC3A1
|
solute carrier family 3 (amino acid transporter heavy chain), member 1
|
1.06
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
1.059
|
|
TSC2
|
tuberous sclerosis 2
|
1.058
|
|
ACVR2A
|
activin A receptor, type IIA
|
1.057
|
|
HP
|
haptoglobin
|
1.057
|
|
ITPR1
|
inositol 1,4,5-trisphosphate receptor, type 1
|
1.056
|
|
ADGRG2
|
adhesion G protein-coupled receptor G2
|
1.055
|
|
PRTN3
|
proteinase 3
|
1.055
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
1.053
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
1.051
|
|
AHR
|
aryl hydrocarbon receptor
|
1.05
|
|
OXA1L
|
oxidase (cytochrome c) assembly 1-like
|
1.049
|
|
MB
|
myoglobin
|
1.048
|
|
FST
|
follistatin
|
1.048
|
|
FLNA
|
filamin A, alpha
|
1.044
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
1.041
|
|
ATRX
|
alpha thalassemia/mental retardation syndrome X-linked
|
1.04
|
|
CELA3B
|
chymotrypsin-like elastase family, member 3B
|
1.034
|
|
CRTAP
|
cartilage associated protein
|
1.033
|
|
PAX1
|
paired box 1
|
1.031
|
|
GFRA1
|
GDNF family receptor alpha 1
|
1.03
|
|
IRS1
|
insulin receptor substrate 1
|
1.029
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
1.025
|
|
MMP2
|
matrix metallopeptidase 2
|
1.022
|
|
TOR1A
|
torsin family 1, member A (torsin A)
|
1.022
|
|
SLC7A9
|
solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9
|
1.02
|
|
DNTT
|
DNA nucleotidylexotransferase
|
1.02
|
|
IL7
|
interleukin 7
|
1.018
|
|
CDX2
|
caudal type homeobox 2
|
1.018
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
1.017
|
|
TCEA3
|
transcription elongation factor A (SII), 3
|
1.017
|
|
SLC22A12
|
solute carrier family 22 (organic anion/urate transporter), member 12
|
1.017
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
1.014
|
|
PIK3C2A
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha
|
1.014
|
|
SLC26A1
|
solute carrier family 26 (anion exchanger), member 1
|
1.014
|
|
KITLG
|
KIT ligand
|
1.013
|
|
NPHS2
|
nephrosis 2, idiopathic, steroid-resistant (podocin)
|
1.013
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
1.013
|
|
THBD
|
thrombomodulin
|
1.013
|
|
SMAD9
|
SMAD family member 9
|
1.012
|
|
KLHL3
|
kelch-like family member 3
|
1.012
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
1.008
|
|
APOC2
|
apolipoprotein C-II
|
1.008
|
|
FOXO1
|
forkhead box O1
|
1.007
|
|
OSTM1
|
osteopetrosis associated transmembrane protein 1
|
1.005
|
|
CYP11A1
|
cytochrome P450, family 11, subfamily A, polypeptide 1
|
1.004
|
|
APOC3
|
apolipoprotein C-III
|
1.003
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
1.002
|
|
TLR2
|
toll-like receptor 2
|
1.002
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
1.001
|
|
MYORG
|
myogenesis regulating glycosidase (putative)
|
1.001
|
